BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maranini B, Ciancio G, Govoni M. Adult-Onset Still's Disease: Novel Biomarkers of Specific Subsets, Disease Activity, and Relapsing Forms. Int J Mol Sci 2021;22:13320. [PMID: 34948117 DOI: 10.3390/ijms222413320] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Duan M, Shen M, Zhou Y, He Y, Guo Z, Ye C, Li J, Zhu L. AIM2 and NLRC4-driven inflammasome activation in adult-onset Still’s disease and the preliminary therapeutic effect exploration of carboxyamidotriazole. Clin Rheumatol 2022. [DOI: 10.1007/s10067-022-06443-1] [Reference Citation Analysis]
2 Rao S, Tsang LS, Zhao M, Shi W, Lu Q. Adult-onset Still’s disease: A disease at the crossroad of innate immunity and autoimmunity. Front Med 2022;9. [DOI: 10.3389/fmed.2022.881431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chen PK, Wey SJ, Chen DY. Interleukin-18: a biomarker with therapeutic potential in adult-onset Still's disease. Expert Rev Clin Immunol 2022;:1-11. [PMID: 35771972 DOI: 10.1080/1744666X.2022.2096592] [Reference Citation Analysis]
4 Winichakoon P, Chanloung W, Nantsupawat T, Louthrenoo W. Adult-Onset Still’s Disease-like Syndrome following COVID-19 Vaccination: A Case Report and Review of the Literature. Vaccines 2022;10:1022. [DOI: 10.3390/vaccines10071022] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Kaleda MI, Fedorov ES. Significance of hyperferritinemia as a diagnostic and prognostic biomarker. Sovremennaâ revmatologiâ 2022;16:74-80. [DOI: 10.14412/1996-7012-2022-2-74-80] [Reference Citation Analysis]